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ABSTRACT 
Chronic subclinical systemic inflammation has a key role in stimulating several chronic 
conditions associated with cardiovascular diseases, cancer, rheumatoid arthritis, diabetes, and 
neurodegenerative diseases. Hence, developing in vivo models of chronic subclinical systemic 
inflammation are essential to the study of the pathophysiology and to measure the 
immunomodulatory agents involved. Male Sprague–Dawley rats were subjected to 
intraperitoneal, intermittent injection with saline, or lipopolysaccharide (LPS) (0.5, 1, 2 mg/kg) 
thrice a week for 30 days. Hematological, biochemical, and inflammatory mediators were 
measured at different timepoints and at the end of the study. The hearts, lungs, kidneys, and 
livers were harvested for histological evaluation. Significant elevation in peripheral blood 
leukocyte includes neutrophils, monocytes, and lymphocytes, as well as the neutrophils-to-
lymphocyte ratio. The pro-inflammatory mediator levels [C-reactive protein, tumor necrosis 
factor (TNF)-α, interleukin (IL)-6, IL-1β, and IL-8] along with the biochemical profile 
(alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl 
transferase, creatine kinase, creatinine, and urea) were increased significantly (P < 0.05) and 
increased the expression of monocyte chemoattractant protein-1 and TNF-β. The 
histopathological changes of heart, lung, kidney, and liver tissues revealed degeneration, 
cellular infiltration of leukocyte in the inflammatory foci and interstitial space, edema, early 
signs of fibrosis, apoptosis, and necrosis. In conclusion, these results indicate that intermittent 
exposure to LPS produces chronic subclinical systemic inflammation in multiple organs 
leading to chronic conditions and supports this model to be a useful preclinical tool for 
developing immunotherapeutic agents that could prevent, or reduce, chronic inflammatory 
diseases associated with, or without, bacterial translocation. 
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